GSP Crop Science Lists at 4% Premium, Rises to 10% Gain

Introduction

Shares of agrochemical manufacturer GSP Crop Science made a decent market debut on March 24, 2026, listing at a premium on both the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE). The listing performance surpassed the muted expectations indicated by the grey market premium ahead of its debut. The stock opened strong and gained further momentum during the trading session, providing modest gains to its initial public offering (IPO) investors.

Listing Performance and Market Response

GSP Crop Science shares began their trading journey on the BSE at ₹332.30 per share, marking a premium of 3.84% over the final issue price of ₹320. On the NSE, the stock listed at ₹328.00, a premium of 2.50%. Following the listing, the share price continued to climb, reaching an intraday high of ₹352.05 on the BSE. This represented a gain of 10.02% for investors who were allotted shares in the IPO. The company's market capitalization stood at ₹1,545.82 crore shortly after listing.

A Look at the IPO Subscription

The ₹400 crore IPO, which was open for subscription from March 16 to March 18, 2026, received a mixed response from investors. The issue was subscribed 1.61 times overall. The response was primarily driven by institutional investors. The portion reserved for Qualified Institutional Buyers (QIBs) was subscribed 2.66 times, while the Non-Institutional Investors (NIIs) category saw a subscription of 3.05 times. In contrast, the retail investor segment showed limited interest, with its allocated portion being subscribed just 0.42 times.

IPO Structure and Offer Details

The public issue was a combination of a fresh issue of shares worth ₹240 crore and an Offer for Sale (OFS) of 50 lakh equity shares, amounting to ₹160 crore at the upper price band. Through the OFS, promoters Vilasben Vrajmohan Shah, Bhavesh Vrajmohan Shah, and Kappa Trust offloaded a part of their holdings. The price band for the IPO was set at ₹304 to ₹320 per share, with a minimum lot size of 46 shares.

Utilization of IPO Proceeds

The proceeds from the Offer for Sale will go to the selling shareholders. The net proceeds from the fresh issue of ₹240 crore are earmarked for specific corporate objectives. The company plans to utilize approximately ₹170 crore to repay or prepay its outstanding borrowings. The remaining funds will be allocated for general corporate purposes, providing financial flexibility for future operations and growth initiatives.

Company Financial Health

GSP Crop Science has demonstrated steady financial growth in recent years. The company's revenue and profitability have shown a consistent upward trend, strengthening its position in the agrochemical sector.

For the fiscal year ended March 2025, the company reported a 36% increase in profit to ₹83.4 crore, while its revenue grew by 11.7% to ₹1,287.4 crore. For the six months ending September 2025, it had already recorded a profit of ₹82.7 crore on a revenue of ₹844.2 crore.

Business Profile and Global Footprint

Based in Ahmedabad, GSP Crop Science is a research-driven company that manufactures a diverse range of agrochemicals, including insecticides, herbicides, fungicides, and plant growth regulators. As of September 2025, the company held 102 patents and had 108 patent applications in process, highlighting its focus on innovation. Its customer base is spread across 20 states in India, and it has a significant international presence, exporting to 37 countries, including the United States, Brazil, Australia, and the UAE.

Key Listing Information

Analysis and Outlook

The successful listing of GSP Crop Science, despite the lukewarm retail subscription, indicates strong confidence from institutional investors in the company's fundamentals and growth prospects. The decision to use a significant portion of the IPO funds to reduce debt is a positive step towards strengthening its balance sheet. With a solid financial track record, a focus on R&D, and an expanding global footprint, the company is positioned to capitalize on opportunities in the domestic and international agrochemical markets. The market will now watch how the company utilizes its stronger financial position to drive future growth.